Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H31F3N4O2 |
| Molecular Weight | 476.5344 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCNC(=O)NC[C@H]1CC[C@H]2[C@@H](NC3=C(C=C(C=C3)C(F)(F)F)[C@H]2O1)C4=CC=CC=C4
InChI
InChIKey=MARIUIDCPUZLKZ-FUKQBSRTSA-N
InChI=1S/C25H31F3N4O2/c1-32(2)13-12-29-24(33)30-15-18-9-10-19-22(16-6-4-3-5-7-16)31-21-11-8-17(25(26,27)28)14-20(21)23(19)34-18/h3-8,11,14,18-19,22-23,31H,9-10,12-13,15H2,1-2H3,(H2,29,30,33)/t18-,19+,22+,23+/m1/s1
| Molecular Formula | C25H31F3N4O2 |
| Molecular Weight | 476.5344 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL4581 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20149654 |
8.0 nM [IC50] |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
92.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
2 mg/m² single, intravenous dose: 2 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
144.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
4 mg/m² single, intravenous dose: 4 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
202.6 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
6 mg/m² single, intravenous dose: 6 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
325.2 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
9 mg/m² single, intravenous dose: 9 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
357.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
14 mg/m² single, intravenous dose: 14 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
680.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
21 mg/m² single, intravenous dose: 21 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
827.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
32 mg/m² single, intravenous dose: 32 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1817 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
48 mg/m² single, intravenous dose: 48 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1563.6 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
72 mg/m² single, intravenous dose: 72 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4757.5 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
108 mg/m² single, intravenous dose: 108 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4275.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
135 mg/m² single, intravenous dose: 135 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
101.6 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
2 mg/m² 1 times / 3 weeks multiple, intravenous dose: 2 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
252.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
4 mg/m² 1 times / 3 weeks multiple, intravenous dose: 4 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
260.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
6 mg/m² 1 times / 3 weeks multiple, intravenous dose: 6 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
352.3 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
9 mg/m² 1 times / 3 weeks multiple, intravenous dose: 9 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
431 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
14 mg/m² 1 times / 3 weeks multiple, intravenous dose: 14 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
430 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
21 mg/m² 1 times / 3 weeks multiple, intravenous dose: 21 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
637.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
32 mg/m² 1 times / 3 weeks multiple, intravenous dose: 32 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1853.9 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
48 mg/m² 1 times / 3 weeks multiple, intravenous dose: 48 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2759.6 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
72 mg/m² 1 times / 3 weeks multiple, intravenous dose: 72 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4895.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
108 mg/m² 1 times / 3 weeks multiple, intravenous dose: 108 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
5897.9 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
135 mg/m² 1 times / 3 weeks multiple, intravenous dose: 135 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1345 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
2 mg/m² single, intravenous dose: 2 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2804 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
4 mg/m² single, intravenous dose: 4 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
3134 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
6 mg/m² single, intravenous dose: 6 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4495 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
9 mg/m² single, intravenous dose: 9 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
6379 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
14 mg/m² single, intravenous dose: 14 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
8883 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
21 mg/m² single, intravenous dose: 21 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
11288 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
32 mg/m² single, intravenous dose: 32 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
27695 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
48 mg/m² single, intravenous dose: 48 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
17659 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
72 mg/m² single, intravenous dose: 72 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
80526 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
108 mg/m² single, intravenous dose: 108 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
85223 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
135 mg/m² single, intravenous dose: 135 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1262 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
2 mg/m² 1 times / 3 weeks multiple, intravenous dose: 2 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2765 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
4 mg/m² 1 times / 3 weeks multiple, intravenous dose: 4 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
3429 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
6 mg/m² 1 times / 3 weeks multiple, intravenous dose: 6 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4972 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
9 mg/m² 1 times / 3 weeks multiple, intravenous dose: 9 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
5078 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
14 mg/m² 1 times / 3 weeks multiple, intravenous dose: 14 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
6514 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
21 mg/m² 1 times / 3 weeks multiple, intravenous dose: 21 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
11508 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
32 mg/m² 1 times / 3 weeks multiple, intravenous dose: 32 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
29408 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
48 mg/m² 1 times / 3 weeks multiple, intravenous dose: 48 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
42140 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
72 mg/m² 1 times / 3 weeks multiple, intravenous dose: 72 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
80700 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
108 mg/m² 1 times / 3 weeks multiple, intravenous dose: 108 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
84899 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
135 mg/m² 1 times / 3 weeks multiple, intravenous dose: 135 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
47.7 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
2 mg/m² single, intravenous dose: 2 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
61.5 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
4 mg/m² single, intravenous dose: 4 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
57.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
6 mg/m² single, intravenous dose: 6 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
58.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
9 mg/m² single, intravenous dose: 9 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
48.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
14 mg/m² single, intravenous dose: 14 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
46.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
21 mg/m² single, intravenous dose: 21 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
60.3 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
32 mg/m² single, intravenous dose: 32 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
48.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
48 mg/m² single, intravenous dose: 48 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
43.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
72 mg/m² single, intravenous dose: 72 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
47.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
108 mg/m² single, intravenous dose: 108 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
50.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
135 mg/m² single, intravenous dose: 135 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
43.1 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
2 mg/m² 1 times / 3 weeks multiple, intravenous dose: 2 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
52.6 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
4 mg/m² 1 times / 3 weeks multiple, intravenous dose: 4 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
57.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
6 mg/m² 1 times / 3 weeks multiple, intravenous dose: 6 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
51.1 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
9 mg/m² 1 times / 3 weeks multiple, intravenous dose: 9 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
51.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
14 mg/m² 1 times / 3 weeks multiple, intravenous dose: 14 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
57.3 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
21 mg/m² 1 times / 3 weeks multiple, intravenous dose: 21 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
53.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
32 mg/m² 1 times / 3 weeks multiple, intravenous dose: 32 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
39.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
48 mg/m² 1 times / 3 weeks multiple, intravenous dose: 48 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
42 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
72 mg/m² 1 times / 3 weeks multiple, intravenous dose: 72 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
43.7 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
108 mg/m² 1 times / 3 weeks multiple, intravenous dose: 108 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
40.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24077982/ |
135 mg/m² 1 times / 3 weeks multiple, intravenous dose: 135 mg/m² route of administration: Intravenous experiment type: MULTIPLE co-administered: |
EMD-534085 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:18:05 GMT 2025
by
admin
on
Mon Mar 31 23:18:05 GMT 2025
|
| Record UNII |
AL67QX8036
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000042440
Created by
admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
|
PRIMARY | |||
|
858668-07-2
Created by
admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
|
PRIMARY | |||
|
DTXSID90235147
Created by
admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
|
PRIMARY | |||
|
23634407
Created by
admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
|
PRIMARY | |||
|
1035647-06-3
Created by
admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
|
SUPERSEDED | |||
|
AL67QX8036
Created by
admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |